Day: April 5, 2021

Pune, India, April 05, 2021 (GLOBE NEWSWIRE) — “The global infusion Pump market size is predicted to reach USD 16.09 billion by 2026, exhibiting a CAGR of 7.1% during the forecast period.” The increasing prevalence of chronic diseases will spur demand for infusion Pump in the forthcoming years. Moreover, the growing advancements in drug delivery systems will boost the market trends during the forecast period. The increasing adoption of advanced treatment techniques will have a positive impact on the infusion Pump industry growth in the foreseeable future. The market size stood at USD 9.28 billion in 2018. The global infusion Pump market report focuses and elaborates the definition, types, applications and major players in detail. Deep analysis about market status, competition pattern, enterprise, advantages and disadvantages of...

Pune, India, April 05, 2021 (GLOBE NEWSWIRE) — The global dental CAD/CAM market size is projected to reach USD 3.95 billion by 2028, exhibiting a CAGR of 8.7% during the forecast period. Fortune Business Insights™ shares this information in its report, titled “Dental CAD/CAM Market, 2021-2028”. As per the report, the value of the market stood at USD 2.06 billion in 2020. A study published by the Lancet in 2017 mentions that nearly 3.5 billion people worldwide have been affected by oral diseases. Even though most dental health conditions are highly preventable, factors, such as poor eating habits, consumption of tobacco and alcohol, and lack of dental care, especially in the young urban population, cause dental problems such as tooth decay, sensitive teeth, and in some cases, even oral cancer. Request a Sample Copy of the Research...

ACEA’s major assets include:Abivertinib (in oral capsule form), a next generation, dual EGFR mutant and BTK inhibitor (BTKi) with a completed NSCLC registrational/Phase 3 trial, Phase 1 B-cell lymphoma study, and ongoing Phase 2 trials in COVID-19 patients with ARDS, and Phase 2 studies for prostate cancer, systemic lupus erythematosus and the ultra-orphan indication of hairy cell leukemia. AC0058, a brain-penetrating, next generation BTK inhibitor in a Phase 1b Lupus trial and IND-enabling studies for multiple sclerosis. AC0939, a next generation FLT-3 inhibitor, is near completion of IND-enabling studies for potential CNS indications. A 1,000,000+ compound library of small molecules and proprietary discovery platform for screening and optimizing potent drug candidates for potential indications in oncology, autoimmune diseases, CNS...

Extends Geographic Footprint to Northwest U.S. and Canada SYRACUSE, IN, April 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Znergy, Inc. (OTC: ZNRG) (the ”Company”) a leading provider of new LED lighting and turnkey LED lighting conversions for businesses, is pleased to announce its acquisition of Quantum Energy, LLC, which has a 47-year history in lighting sales and installation specializing in LED conversions for businesses. The acquisition is expected to result in greater efficiencies and further increase Znergy’s nationwide market share.  Znergy Chief Executive Officer, Dave Baker, commented, “The combination was formed to strengthen our geographic market in the northwestern United States and Canada allowing greater access. The integration of both companies will take place over the next few months.”  Quantum Energy has an extensive...